- AVDL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Avadel Pharmaceuticals (AVDL) 10-K/A2015 FY Annual report (amended)
Filed: 29 Apr 16, 12:00am
Exhibit 31.4
Rule 13a-14(a) Certification of the Chief Financial Officer
I, Michael F. Kanan, certify that:
1. | I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Flamel Technologies S.A.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 29, 2016
/s/ Michael F. Kanan | |
Michael F. Kanan | |
Senior Vice President and Chief Financial Officer | |
(principal financial officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.